S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in

Cronos Group Stock Forecast, Price & News

-0.09 (-0.84 %)
(As of 01/22/2021 12:00 AM ET)
Today's Range
Now: $10.65
50-Day Range
MA: $8.57
52-Week Range
Now: $10.65
Volume2.83 million shs
Average Volume7.10 million shs
Market Capitalization$3.79 billion
P/E Ratio44.38
Dividend YieldN/A
Cronos Group Inc. operates as a cannabinoid company in the United States and internationally. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through ecommerce, retail, and hospitality partner channels. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. Its brand portfolio includes PEACE NATURALS, a global wellness platform; adult-use brands comprise COVE and Spinach; and hemp-derived CBD brands consists of Lord Jones and PEACE+. Cronos Group Inc. is based in Toronto, Canada.
Cronos Group logo


Overall MarketRank

0.66 out of 5 stars

Medical Sector

1236th out of 1,923 stocks

Medicinals & Botanicals Industry

16th out of 33 stocks

Analyst Opinion: 1.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medicinals & botanicals
Current SymbolNASDAQ:CRON



Sales & Book Value

Annual Sales$25.64 million
Cash Flow$0.72 per share
Book Value$5.01 per share


Net Income$1.17 billion


Market Cap$3.79 billion
Next Earnings Date3/29/2021 (Estimated)
-0.09 (-0.84 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CRON News and Ratings via Email

Sign-up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Cronos Group (NASDAQ:CRON) Frequently Asked Questions

How has Cronos Group's stock been impacted by Coronavirus?

Cronos Group's stock was trading at $5.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CRON shares have increased by 96.9% and is now trading at $10.65.
View which stocks have been most impacted by COVID-19

Is Cronos Group a buy right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 2 sell ratings, 4 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" Cronos Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRON, but not buy additional shares or sell existing shares.
View analyst ratings for Cronos Group
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Cronos Group?

Wall Street analysts have given Cronos Group a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cronos Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cronos Group's next earnings date?

Cronos Group is scheduled to release its next quarterly earnings announcement on Monday, March 29th 2021.
View our earnings forecast for Cronos Group

How were Cronos Group's earnings last quarter?

Cronos Group Inc. (NASDAQ:CRON) announced its earnings results on Thursday, November, 5th. The company reported $0.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.06) by $0.25. The business earned $11.36 million during the quarter, compared to analysts' expectations of $14.80 million. Cronos Group had a net margin of 266.31% and a negative trailing twelve-month return on equity of 1.61%. The company's quarterly revenue was up 96.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.62 EPS.
View Cronos Group's earnings history

What price target have analysts set for CRON?

8 equities research analysts have issued 1 year target prices for Cronos Group's shares. Their forecasts range from $5.00 to $11.00. On average, they anticipate Cronos Group's stock price to reach $8.19 in the next twelve months. This suggests that the stock has a possible downside of 23.1%.
View analysts' price targets for Cronos Group
or view Wall Street analyst' top-rated stocks.

Are investors shorting Cronos Group?

Cronos Group saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 28,510,000 shares, a drop of 20.0% from the December 15th total of 35,620,000 shares. Based on an average daily volume of 5,370,000 shares, the short-interest ratio is currently 5.3 days. Currently, 15.7% of the shares of the company are sold short.
View Cronos Group's Short Interest

Who are some of Cronos Group's key competitors?

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include (CGC), Aurora Cannabis (ACB), Tilray (TLRY), (APHA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and OrganiGram (OGI).

Who are Cronos Group's key executives?

Cronos Group's management team includes the following people:
  • Mr. Michael Ryan Gorenstein, Exec. Chairman (Age 34, Pay $333.57k)
  • Mr. Jerry Filomena Barbato, Chief Financial Officer (Age 45, Pay $299.63k)
  • Ms. Xiuming Shum, Exec. VP of Legal and Regulatory Affairs & Corp. Sec. (Age 35, Pay $190.18k)
  • Mr. Kurt Thomas Schmidt B.Sc., M.B.A., Pres & CEO (Age 64)
  • Mr. Shayne J. Laidlaw, Director of Investor Relations & Strategy
  • Mr. Eric Klein, Head of Marketing
  • Ms. Shannon Buggy, Sr. VP & Global Head of People
  • Ms. Anna Shlimak, Sr. VP of Corp. Affairs (Age 35)
  • Dr. Todd K. Abraham, Chief Innovation Officer (Age 66)
  • Puneet Mathur, VP & Controller

What is Cronos Group's stock symbol?

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Who are Cronos Group's major shareholders?

Cronos Group's stock is owned by a number of institutional and retail investors. Top institutional investors include Kestra Advisory Services LLC (0.02%), Traynor Capital Management Inc. (0.01%), Kestra Private Wealth Services LLC (0.01%), International Assets Investment Management LLC (0.00%) and Global Retirement Partners LLC (0.00%). Company insiders that own Cronos Group stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham.
View institutional ownership trends for Cronos Group

Which major investors are buying Cronos Group stock?

CRON stock was acquired by a variety of institutional investors in the last quarter, including Traynor Capital Management Inc., Kestra Advisory Services LLC, International Assets Investment Management LLC, Kestra Private Wealth Services LLC, and Global Retirement Partners LLC.
View insider buying and selling activity for Cronos Group
or or view top insider-buying stocks.

How do I buy shares of Cronos Group?

Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cronos Group's stock price today?

One share of CRON stock can currently be purchased for approximately $10.65.

How big of a company is Cronos Group?

Cronos Group has a market capitalization of $3.79 billion and generates $25.64 million in revenue each year. The company earns $1.17 billion in net income (profit) each year or $0.67 on an earnings per share basis. Cronos Group employs 631 workers across the globe.

What is Cronos Group's official website?

The official website for Cronos Group is www.thecronosgroup.com.

How can I contact Cronos Group?

Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The company can be reached via phone at 416-504-0004.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.